WALTHAM, Mass. (AP) 鈥� WALTHAM, Mass. (AP) 鈥� Crescent Biopharma, Inc. (CBIO) on Wednesday reported a loss of $23.3 million in its first quarter.
The Waltham, Massachusetts-based company said it had a loss of 70 cents per share.
The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 85 cents per share.
The biotechnology company posted revenue of $1 million in the period.
_____
This story was generated by (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a at https://www.zacks.com/ap/CBIO
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
